Skip to main content

RX Updates

GPA: Patient and Physician Perspectives on ENT Manifestations

Sponsored by Amgen
Tune in to Dr. Spiera and Dr. Lebovics to learn about ear, nose, and throat manifestations in granulomatosis with polyangiitis (GPA) and gain insights into daily life of a person living with severe active GPA. USA-569-80242

SpA and Comorbidities: The Flip Side

Sponsored by Novartis Pharmaceuticals Corporation
Delve into this update that sheds light on how much impact comorbidities actually have on SpA disease activity and patients’ lives.

Collaborations in Rheumatology: A Conversation With Gastroenterology

Sponsored by AbbVie Medical Affairs
Listen as rheumatologist Dr. Kathryn Dao and gastroenterologist Dr. Amar Naik share similarities and differences in their clinical perspectives, including a conversation on some of the benefits and risks of a JAKi in each patient population.

Gout Flares: Taking a Deeper Look

Sponsored by Novartis Pharmaceuticals Corporation
Dr. Naomi Schlesinger takes a deep dive into exploring how gout flares develop and can be managed in this engaging video.

Psoriasis for Rheumatologists

Sponsored by AbbVie Medical Affairs
Watch rheumatologist and dermatologist Dr. Saakshi Khattri and rheumatologist Dr. Shikha Singla discuss what rheumatologists can learn from psoriasis trials when making clinical decisions about psoriatic arthritis.

2022 ASAS‐EULAR Guideline Updates in Treating axSpA

Sponsored by Novartis Pharmaceuticals Corporation
Learn about enhancing patient care in axSpa through this engaging video series as Dr. Lianne Gensler and Dr. Atul Deodhar walk through the updates to the ASAS-EULAR Guidelines. Each video in this series (total watch time 15 mins) is dedicated to creating a better understanding of treatment and patient management in axSpA.

Diagnosis of PMR

Nine perspectives now available: Red Flags in the Diagnosis of PMR; Epidemiology of PMR; Role of the PCP in Diagnosis and Care; Importance of Diagnostic Imaging; ESR/CRP in PMR; PMR Must Rule Outs; Which PMR Patients Should Rheumatologists See?; Is There Hidden GCA?; and PMR Mimics.

Hard Decisions in RA

Sponsored by RheumNow
Eight debates and perspectives on Hard Decisions in RA now available.

When do you consider switching vs cycling in patients with RA after first TNFi failure?

Sponsored by AbbVie Medical Affairs
Watch rheumatologists Dr. Roy Fleischmann and Dr. Janet Pope discuss treatment options for patients with RA who have failed a TNFi. The experts consider switching to an alternate MOA vs cycling to another TNFi.

Composite Measure to Inform Management of Bio-naïve Patients with Psoriatic Arthritis

Sponsored by AbbVie Medical Affairs
Listen as rheumatologists Dr. Philip Mease and Dr. Saakshi Khattri share their insights on using composite measures to manage patients with psoriatic arthritis. In this podcast, they discuss four composite measures used in trials of an IL-23 inhibitor.

Vasculitis Update

Sponsored by Novartis Pharmaceuticals Corporation
GCA and PMR: Overview of Diseases Giant cell arteritis (GCA) is the most common vasculitis in the United States, with polymyalgia rheumatica (PMR) being the second most common inflammatory rheumatic disease.1-3 The 2 disorders share an overlap in clinical presentation although they have different diagnoses. Of the patients with a primary diagnosis of GCA, 40% to 60% have PMR, whereas of patients with a primary diagnosis of PMR, 15% to 20% have GCA.1

Long-Term Efficacy and Safety of a JAKi in RA

Sponsored by AbbVie Medical Affairs
Watch rheumatologist Dr. Stan Cohen share his clinical perspective on long-term data with a JAKi in RA. In this video, Dr. Cohen discusses the potential benefits and risks of using a JAKi in TNFi-IR patients.